MetaCap

Who Owns Prime Medicine Stock?

NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.55-0.29 (-7.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
57.48%
Institutional holders
251
  • Institutions 57.5%
  • Insiders 17.0%
  • Public and other 25.5%

Who owns Prime Medicine stock?

Institutional investors own about 57.5% of Prime Medicine's shares, spread across 251 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 17.01% of PRME.

The largest institutional holders are Arch Venture Management, Llc (10.16%), Alphabet Inc. (9.10%) and Blackrock Inc. (5.89%). Together, the top 10 institutions control 44.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PRME positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of PRME

Prime Medicine top institutional holders
InstitutionShares% HeldChange
Arch Venture Management, Llc18.49M10.16%+100.0%
Alphabet Inc.16.56M9.10%0.0%
Blackrock Inc.10.72M5.89%+11.6%
ARK Investment Management, LLC10.04M5.52%+20.3%
State Street Corporation6.15M3.38%-18.9%
Vanguard Capital Management LLC4.58M2.52%+1.3%
T. Rowe Price Investment Management, Inc.4.56M2.50%-13.0%
Balyasny Asset Management LP3.56M1.96%-10.3%
Casdin Capital, LLC3.17M1.74%0.0%
Woodline Partners LP3.01M1.65%+0.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of PRME

Prime Medicine top fund holders
FundShares% Held
ARK ETF Trust-ARK Genomic Revolution ETF8.01M4.40%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF3.62M1.99%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.12M1.72%
ARK Venture Fund2.94M1.61%
iShares Trust-iShares Russell 2000 ETF2.44M1.34%
T. Rowe Price Small-Cap Value Fund, Inc.1.36M0.75%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.30M0.71%
T. Rowe Price Small-Cap Stock Fund, Inc.1.22M0.67%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.04M0.57%
TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust888.07K0.49%

Frequently asked questions

Who is the largest shareholder of Prime Medicine?

Arch Venture Management, Llc is the largest institutional shareholder of PRME, owning 10.16% of shares outstanding (18.49M shares) as of its latest 13F filing.

What percentage of Prime Medicine is owned by institutions?

Institutions own about 57.5% of PRME shares and 69.3% of the public float.

How much of Prime Medicine do insiders own?

Insiders, such as officers and directors, own about 17.01% of PRME shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related